Right ventricular-pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis

dc.contributor.authorStassen Jan
dc.contributor.authorGalloo Xavier
dc.contributor.authorHirasawa Kensuke
dc.contributor.authorChimed Surenjav
dc.contributor.authorAjmone Marsan Nina
dc.contributor.authorDelgado Victoria
dc.contributor.authorvan der Bijl Pieter
dc.contributor.authorBax Jeroen J.
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.converis.publication-id174905969
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/174905969
dc.date.accessioned2022-10-28T13:50:05Z
dc.date.available2022-10-28T13:50:05Z
dc.description.abstractAims Chronic pressure overload and right ventricular (RV) dysfunction can lead to RV-pulmonary artery (PA) uncoupling in patients with heart failure. The evolution and prognostic values of RV-PA coupling assessed by echocardiography in patients undergoing cardiac resynchronization therapy (CRT) have not been thoroughly investigated. The aim of this study was to evaluate the evolution and prognostic value of tricuspid annular plane systolic excursion (TAPSE)/pulmonary artery systolic pressure (PASP) ratio in CRT recipients.Methods and results The RV-PA coupling was measured non-invasively with echocardiography using the TAPSE/PASP ratio at baseline and 6 month follow-up in CRT recipients. The cut-off value for TAPSE/PASP uncoupling was derived from spline curve analysis (i.e. <0.45 mm/mmHg). The primary endpoint was all-cause mortality. A total of 807 patients (age 66 +/- 11 years, 76% men) were analysed. During a median follow-up of 97 (54-143) months, 483 (60%) patients died. Survival rates at 3 and 5 year follow-up were significantly lower for patients with a TAPSE/PASP ratio <0.45 mm/mmHg (76% and 58%, respectively), compared with those with a TAPSE/PASP ratio >= 0.45 mm/mmHg (91% and 82%, respectively) (P < 0.001). On multivariable analysis, TAPSE/PASP ratio <0.45 mm/mmHg (hazard ratio 1.437; 95% confidence interval: 1.145-1.805; P = 0.002) was independently associated with all-cause mortality, whereas TAPSE <17 mm (hazard ratio 1.237; 95% confidence interval: 0.990-1.546; P = 0.061) was not. In addition, no improvement of the TAPSE/PASP ratio after CRT implantation was independently associated with worse survival.Conclusions The TAPSE/PASP ratio at baseline is independently associated with long-term outcomes in CRT recipients. The baseline TAPSE/PASP ratio has incremental value over TAPSE, which does not take account of RV afterload. A lack of improvement in the TAPSE/PASP ratio after CRT implantation is associated with worse survival.
dc.identifier.eissn2055-5822
dc.identifier.jour-issn2055-5822
dc.identifier.olddbid184627
dc.identifier.oldhandle10024/167721
dc.identifier.urihttps://www.utupub.fi/handle/11111/38684
dc.identifier.urlhttps://doi.org/10.1002/ehf2.13857
dc.identifier.urnURN:NBN:fi-fe2022081154676
dc.language.isoen
dc.okm.affiliatedauthorBax, Jeroen
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherWILEY PERIODICALS, INC
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1002/ehf2.13857
dc.relation.ispartofjournalESC Heart Failure
dc.relation.issue3
dc.relation.volume9
dc.source.identifierhttps://www.utupub.fi/handle/10024/167721
dc.titleRight ventricular-pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis
dc.year.issued2022

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
ESC Heart Failure - 2022 - Stassen - Right ventricular pulmonary artery coupling in cardiac resynchronization therapy .pdf
Size:
588.39 KB
Format:
Adobe Portable Document Format